Skip to content

Carbimazole

Overview

Medical Information

Dosage Information

Side Effects

Safety Information

Reference Information

Frequently Asked Questions

What is the recommended dosage for Carbimazole?

Adults: 20-60 mg/day initially, then reduced to 5-15 mg/day for maintenance. Children (3-17 years): 15 mg/day initially, adjusted based on response.

What are the most serious side effects of Carbimazole?

Agranulocytosis (low white blood cell count), liver damage, and acute pancreatitis.

Can Carbimazole be used during pregnancy?

It should generally be avoided, especially in the first trimester, due to a risk of birth defects. Propylthiouracil is usually preferred. If Carbimazole is used, it should be the lowest effective dose and under close monitoring.

Can Carbimazole be used during breastfeeding?

Carbimazole passes into breast milk. If the maternal dose is less than 30mg daily, the risk to the infant is minimal. Infant thyroid monitoring is advisable, especially if using higher doses.

How does Carbimazole work?

It inhibits the enzyme thyroid peroxidase, blocking the synthesis of thyroid hormones (T3 and T4).

How long does it take for Carbimazole to work?

Patients usually start to feel better within a few weeks, but it can take several months to achieve normal thyroid hormone levels.

What should patients do if they experience a sore throat or fever while taking Carbimazole?

They should stop the medication immediately and contact their doctor, as this may indicate agranulocytosis.

What are the common drug interactions with Carbimazole?

Anticoagulants (e.g., warfarin), theophylline, and digoxin.

What should be monitored in patients taking Carbimazole?

Thyroid function tests (TSH, Free T4, T3), Complete Blood Count.

Is Carbimazole safe for long-term use?

Yes, but regular monitoring of thyroid function and blood counts is necessary. This information is current as of February 16, 2025. As medical knowledge is constantly evolving, it is essential to consult updated resources and guidelines for the latest information.